Published in J Nutr on June 01, 1982
Zinc is a novel intracellular second messenger. J Cell Biol (2007) 2.46
Interactions of malnutrition and immune impairment, with specific reference to immunity against parasites. Parasite Immunol (2006) 1.24
Zinc transporter Znt5/Slc30a5 is required for the mast cell-mediated delayed-type allergic reaction but not the immediate-type reaction. J Exp Med (2009) 0.97
Zinc requirement for macrophage function: effect of zinc deficiency on uptake and killing of a protozoan parasite. Immunology (1989) 0.91
Dietary zinc deficiency in rodents: effects on T-cell development, maturation and phenotypes. Nutrients (2012) 0.84
The influence of zinc in mice on infection with Angiostrongylus cantonensis. Parasitol Res (2004) 0.75
Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun (1978) 32.33
Correlation of the highest-energy cosmic rays with nearby extragalactic objects. Science (2007) 2.57
The effect of chaotropic ions on the dissociation of antigen-antibody complexes. Biochemistry (1967) 2.52
Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry. Cytometry (1992) 2.30
Effects of complement depletion in experimental chagas disease: immune lysis of virulent blood forms of Trypanosoma cruzi. Infect Immun (1975) 2.17
Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease. Gut (2007) 1.98
Phagocytosis: a defense mechanism against infection with Trypanosoma cruzi. J Immunol (1974) 1.81
Apoptosis plays a distinct role in the loss of precursor lymphocytes during zinc deficiency in mice. J Nutr (2002) 1.76
Mechanisms of resistance against experimental Trypanosoma cruzi infection: the importance of antibodies and antibody-forming capacity in the Biozzi high and low responder mice. J Immunol (1976) 1.74
Enhancing effects of gamma interferon on phagocytic cell association with and killing of Trypanosoma cruzi. Infect Immun (1985) 1.62
Evaluation of glucocorticoid-induced DNA fragmentation in mouse thymocytes by flow cytometry. Cell Prolif (1991) 1.60
The effects of bacterial endotoxin on the infection of mice with Trypanosoma cruzi. J Protozool (1972) 1.58
Isolation and fractionation of the photosynthetic membranous organelles from Rhodopseudomonas spheroides. J Bacteriol (1971) 1.58
AMPA/kainate antagonist LY293558 reduces capsaicin-evoked hyperalgesia but not pain in normal skin in humans. Anesthesiology (1998) 1.57
Isolation of Trypanosoma cruzi from blood. J Parasitol (1974) 1.53
Recombinant tumor necrosis factor enhances macrophage destruction of Trypanosoma cruzi in the presence of bacterial endotoxin. J Immunol (1988) 1.52
Measurement of the depth of maximum of extensive air showers above 10{18} eV. Phys Rev Lett (2010) 1.48
Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21. Gut (2006) 1.47
Identification and characterization of a new subset of rat T lymphocytes. J Immunol (1978) 1.43
Zinc: health effects and research priorities for the 1990s. Environ Health Perspect (1994) 1.42
Immunologic deficiency during experimental Chagas' disease (Trypanosoma cruzi infection): role of adherent, nonspecific esterase-positive splenic cells. J Immunol (1982) 1.39
Rapid quantitation of apoptosis in pure and heterogeneous cell populations using flow cytometry. J Immunol Methods (1994) 1.36
The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas. Clin Cancer Res (2001) 1.33
Effect of zinc deficiency on the immune response of the young adult A/J mouse. J Nutr (1977) 1.29
Interrelationships between zinc and immune function. Fed Proc (1986) 1.29
Novel mechanism for Trypanosoma cruzi-induced suppression of human lymphocytes. Inhibition of IL-2 receptor expression. J Immunol (1988) 1.26
Mechanisms of action of "lymphocyte-activating factor" (LAF). III. Evidence that LAF acts on stimulated lymphocytes by raising cyclic GMP in G1. J Immunol (1978) 1.22
Mechanisms of natural resistance to trypanosomal infection. Role of complement in avian resistance to Trypanosoma cruzi infection. Immunology (1976) 1.22
Fibronectin enhances macrophage association with invasive forms of Trypanosoma cruzi. J Immunol (1984) 1.21
Chronic elevation of plasma corticosterone causes reductions in the number of cycling cells of the B lineage in murine bone marrow and induces apoptosis. Immunology (1993) 1.17
Destruction of bloodstream forms of Trypanosoma cruzi by eosinophil granule major basic protein. Am J Trop Med Hyg (1981) 1.17
Experimental Chagas' disease: kinetics of lymphocyte responses and immunological control of the transition from acute to chronic Trypanosoma cruzi infection. Infect Immun (1981) 1.17
Changes in Trypanosoma cruzi infectivity by treatments that affect calcium ion levels. Mol Biochem Parasitol (1994) 1.15
Cross-reactivity of lytic antibodies against blood forms of Trypanosoma cruzi. J Parasitol (1976) 1.15
Competition for antigen by cell populations having receptors with the same specificity but of different idiotype. J Immunol (1975) 1.14
Further characterization of the role of corticosterone in the loss of humoral immunity in zinc-deficient A/J mice as determined by adrenalectomy. J Immunol (1980) 1.14
Lactoferrin effects on phagocytic cell function. I. Increased uptake and killing of an intracellular parasite by murine macrophages and human monocytes. J Immunol (1985) 1.14
Thymus-dependent control of host defense mechanisms against Trypanosoma cruzi infection. Infect Immun (1979) 1.14
Pneumocephalus and tension pneumocephalus after posterior fossa surgery in the sitting position: a prospective study. Acta Neurochir (Wien) (1986) 1.14
On evasion of Trypanosoma cruzi from the host immune response. Lymphoproliferative responses to trypanosomal antigens during acute and chronic experimental Chagas' disease. Immunology (1981) 1.14
Inhibition of mitogen-induced proliferation of mouse T and B lymphocytes by bloodstream forms of Trypanosoma cruzi. J Immunol (1983) 1.13
Knockout of the glutamate dehydrogenase gene in bloodstream Trypanosoma brucei in culture has no effect on editing of mitochondrial mRNAs. Mol Biochem Parasitol (1999) 1.12
Arginine decarboxylase inhibitors reduce the capacity of Trypanosoma cruzi to infect and multiply in mammalian host cells. Proc Natl Acad Sci U S A (1987) 1.11
Growth of isolated amastigotes of Trypanosoma cruzi in cell-free medium. J Protozool (1982) 1.10
Isolation and characterization of a bacteriochlorophyll-containing protein from Rhodopseudomonas spheroides. J Biol Chem (1972) 1.08
The effect of restricted dietary intake on the antibody mediated response of the zinc deficient A/J mouse. J Nutr (1978) 1.07
Role of inflammatory cells in Chagas' disease. II. Interactions of mouse macrophages and human monocytes with intracellular forms of Trypanosoma cruzi: uptake and mechanism of destruction. J Immunol (1984) 1.06
Suppression of human lymphocyte responses by Trypanosoma cruzi. Immunology (1987) 1.06
Human herpesvirus 6 infection in neoplastic and normal brain tissue. J Med Virol (2001) 1.06
Osteoblastoma of the calvaria: report of two cases diagnosed with MRI and clinical review. Neurosurg Rev (1997) 1.06
Regeneration of T-cell helper function in zinc-deficient adult mice. Proc Natl Acad Sci U S A (1978) 1.06
Effects of IL-4 on macrophage functions: increased uptake and killing of a protozoan parasite (Trypanosoma cruzi). Immunology (1989) 1.06
Enhancement of resistance and suppression of immunization against experimental Trypanosoma cruzi infection by Corynebacterium parvum. Infect Immun (1975) 1.05
Inhibitory action of elevated levels of adenosine-3':5' cyclic monophosphate on phagocytosis: effects on macrophage-Trypanosoma cruzi interaction. J Immunol (1982) 1.04
Sarcoma metastatic to the brain: a series of 15 cases. Surg Neurol (1998) 1.03
Ocular echometry in the diagnosis of congenital glaucoma. Arch Ophthalmol (1982) 1.03
Cytotoxic effects of normal sera on lymphoid cells. III. Selective killing of mouse T cells by normal guinea pig serum. J Immunol (1977) 1.03
Glucocorticoids and irradiation-induced apoptosis in normal murine bone marrow B-lineage lymphocytes as determined by flow cytometry. Immunology (1993) 1.02
Selective suppressive effects of Trypanosoma cruzi on activated human lymphocytes. Infect Immun (1989) 1.01
Characterization of the antiviral activity produced during Trypanosoma cruzi infection and protective effects of exogenous interferon against experimental Chagas' disease. J Parasitol (1982) 1.00
Role of polymorphonuclear cells in Chagas' disease. I. Uptake and mechanisms of destruction of intracellular (amastigote) forms of Trypanosoma cruzi by human neutrophils. J Immunol (1983) 1.00
Stimulatory effects of leukotriene B4 on macrophage association with and intracellular destruction of Trypanosoma cruzi. J Immunol (1985) 0.99
Silencing of SH-PTP2 defines a crucial role in the inactivation of epidermal growth factor receptor by 5-aminosalicylic acid in colon cancer cells. Cell Death Differ (2006) 0.99
Toxic effects produced or mediated by human eosinophil granule components on Trypanosoma cruzi. Am J Trop Med Hyg (1988) 0.98
Role of inflammatory cells in Chagas' disease. I. Uptake and mechanism of destruction of intracellular (amastigote) forms of Trypanosoma cruzi by human eosinophils. J Immunol (1984) 0.98
Large intrathoracic meningocele in a patient with neurofibromatosis: technical report. Neurosurg Rev (1996) 0.98
Trypanosoma cruzi inhibits the expression of CD3, CD4, CD8, and IL-2R by mitogen-activated helper and cytotoxic human lymphocytes. J Immunol (1990) 0.98
Functional capacity of the residual lymphocytes from zinc-deficient adult mice. Br J Nutr (1993) 0.97
Antibody-independent activation of the alternative complement pathway in human serum by parasitic cells. Immunology (1977) 0.97
Physiological responses to starvation in the European eel (Anguilla anguilla): effects on haematological, biochemical, non-specific immune parameters and skin structures. Fish Physiol Biochem (2008) 0.96
Phase I chemotherapy study of biochemical modulation of folinic acid and fluorouracil by gemcitabine in patients with solid tumor malignancies. J Clin Oncol (2000) 0.96
Suprasellar monomorphous pilomyxoid neoplasm: an ultastructural analysis. Clin Neuropathol (2001) 0.95
Retinal toxicity in human immunodeficiency virus-infected children treated with 2',3'-dideoxyinosine. Am J Ophthalmol (1992) 0.95
Biochemical requirements for intracellular invasion by Trypanosoma cruzi: protein synthesis. J Protozool (1982) 0.95
Anti-inflammatory effects of chemically modified tetracyclines by the inhibition of nitric oxide and interleukin-12 synthesis in J774 cell line. Int Immunopharmacol (2001) 0.95
Increased serum levels of an interferon-like activity during the acute period of experimental infection with different strains of Trypanosoma cruzi. Am J Trop Med Hyg (1981) 0.94
Retinal toxicity after high-dose cisplatin therapy. J Clin Oncol (1985) 0.94
Epidermoids of the cerebellopontine angle (cpa): usefulness of CT scan. Acta Neurochir (Wien) (1980) 0.93
Preferential induction of apoptosis in mouse CD4+CD8+ alpha beta TCRloCD3 epsilon lo thymocytes by zinc. J Cell Physiol (1995) 0.93
Treatment of life-threatening type I refractory coeliac disease with long-term infliximab. Dig Liver Dis (2007) 0.93
Antibody-dependent killing of bloodstream forms of Trypanosoma cruzi by human peripheral blood leukocytes. Am J Trop Med Hyg (1979) 0.93
Mechanisms of development of immunosuppression during Trypanosoma infections. Parasitol Today (1993) 0.92
Decreased human IL-2 receptor expression due to a protozoan pathogen. Immunol Today (1989) 0.92
Cytotoxic effects of normal sera on lymphoid cells. I. Antibody-independent killing of heterologous thymocytes by guinea pig, rabbit, and human sera: role of the alternative pathway of complement activation. Cell Immunol (1977) 0.92
Inhibition of macrophage-Trypanosoma cruzi interaction by concanavalin A and differential binding of bloodstream and culture forms to the macrophage surface. J Parasitol (1982) 0.91
Zinc requirement for macrophage function: effect of zinc deficiency on uptake and killing of a protozoan parasite. Immunology (1989) 0.91
Effects of human colony-stimulating factor on the uptake and destruction of a pathogenic parasite (Trypanosoma cruzi) by human neutrophils. J Immunol (1986) 0.91
Gastric adenomas: relationship between clinicopathological findings, Helicobacter pylori infection, APC mutations and COX-2 expression. Ann Oncol (2006) 0.91
Susceptibility of insect-borne, metacyclic forms of Trypanosoma cruzi to antibody-mediated mechanisms of destruction. Am J Trop Med Hyg (1983) 0.91
A report on radiation-induced gliomas. Cancer (1991) 0.90
Host cell invasion by Trypanosoma cruzi: role of cell surface galactose residues. Biochem Biophys Res Commun (1984) 0.90
Observation of the suppression of the flux of cosmic rays above 4 x 10 (19) eV. Phys Rev Lett (2008) 0.90
Role of inflammatory cells in Chagas' disease. III. Kinetics of human eosinophil activation upon interaction with parasites (Trypanosoma cruzi). J Immunol (1986) 0.90
Biochemical evidence for the presence of arginine decarboxylase activity in Trypanosoma cruzi. J Parasitol (1992) 0.90
Phase I clinical trial of alitretinoin and tamoxifen in breast cancer patients: toxicity, pharmacokinetic, and biomarker evaluations. J Clin Oncol (2001) 0.89
Cavernous angiomas of the nervous system in Italy: clinical and genetic study. Neurol Sci (2000) 0.89
Carnitine and acylcarnitine levels of human peripheral blood lymphocytes and mononuclear phagocytes. Biochim Biophys Acta (1989) 0.89
Inhibition of antibody-dependent eosinophil-mediated cytotoxicity by heparin. J Immunol (1982) 0.88